Skip to main content
Menu
US

AlphaLISA Human GM-CSF Detection Kit, 500 Assay Points

The AlphaLISA™ Human Granulocyte/Macrophage Colony-Stimulating Factor (GM-CSF) Detection Kit is designed for detection and quantitation of human GM-CSF in serum, buffered solution or cell culture medium in a homogeneous (no-wash steps, no separation steps) assay.

For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).

Feature Specification
Application Protein Quantification
Dynamic Range 1.6 - 10,000 pg/mL
Limit of Detection 1.6 pg/mL
Sample Volume 5 µL

The AlphaLISA™ Human Granulocyte/Macrophage Colony-Stimulating Factor (GM-CSF) Detection Kit is designed for detection and quantitation of human GM-CSF in serum, buffered solution or cell culture medium in a homogeneous (no-wash steps, no separation steps) assay.

For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).

Product Variants
Unit Size: 500 Assay Points
Part #:
AL216C
List Price
USD 2,392.00
Unit Size: 5,000 Assay Points
Part #:
AL216F
List Price
USD 15,950.00

Overview

Formats:

  • Our 500 assay point kit allows you to run 500 wells in 96-well or 384-well format, using a 50 µL reaction volume (5 µL of sample).
  • Our 5,000 assay point kit allows you to run 5,000 wells in 96-well or 384-well format, using a 50 µL reaction volume (5 µL of sample).

Features:

  • No-wash steps, no separation steps
  • ELISA alternative technology
  • Sensitive detection
  • Broad sample compatibility
  • Small sample volume
  • Results in less than 3 hours
  • Half the time of an ELISA assay

Colony-stimulating factors (CSFs) are proteins necessary for the survival, proliferation, and differentiation of hematopoietic progenitor cells. The human Granulocyte/Macrophage colony-stimulating factor (GM-CSF) is a ~23 kDa glycosylated protein (144-aa), encoded by the CSF2 gene. It has been originally purified from culture media conditioned by lung tissue from endotoxin injected mice, having the capacity to stimulate the formation of both granulocyte and macrophage colonies.

AlphaLISA technology allows the detection of molecules of interest in a no-wash, highly sensitive, quantitative assay. In an AlphaLISA assay, a biotinylated anti-analyte antibody binds to the Streptavidin-coated Donor beads while another anti-analyte antibody is conjugated to AlphaLISA Acceptor beads. In the presence of the analyte, the beads come into close proximity. The excitation of the Donor beads causes the release of singlet oxygen molecules that triggers a cascade of energy transfer in the Acceptor beads, resulting in a sharp peak of light emission at 615 nm.

Specifications

Application
Protein Quantification
Automation Compatible
Yes
Brand
AlphaLISA
Detection Modality
Alpha
Dynamic Range
1.6 - 10,000 pg/mL
Host Species
Mouse
Limit of Detection
1.6 pg/mL
Product Group
Kit
Sample Volume
5 µL
Shipping Conditions
Shipped in Blue Ice
Target
GM-CSF
Target Class
Cytokines
Target Species
Human
Technology
Alpha
Therapeutic Area
Inflammation
Unit Size
500 Assay Points

Video gallery

Resources

Are you looking for resources, click on the resource type to explore further.

1-4 of 4 Resources
Whitepaper Icon
Whitepaper
Learning from our ancestors: can we be better prepared for the next pandemic?

In a recent study, a team of international researchers used genomic data from modern human populations to better understand how...

Flyer Icon
Flyer
No-wash cytokine assay solutions

Cytokines play a vital role in both innate and adaptive immunity and are known for their ability to exert diverse functions on...

Flyer Icon
Flyer
Reagent solutions for autoimmunity research.

Advance your autoimmune disease research and benefit from Revvity broad offering of reagent technologies

Flyer Icon
Flyer
Solutions to advance your CART-T cell research

Chimeric antigen receptor (CAR) T-cell therapy has transformed the field of immuno-oncology providing a novel approach to treating...

Scroll Icon